Skip to main content

Advertisement

SpringerLink
Log in

Paralytic ileus after planned abdominal surgery in a patient on treatment with erenumab

  • CE-Research Letter to the Editor
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Deen M, Correnti E, Kamm K, Kelderman T, Papetti L, Rubio-Beltrán E, Vigneri S, Edvinsson L, Maassen Van Den Brink A, On behalf of the European Headache Federation School of Advanced Studies (EHF-SAS) (2017) Blocking CGRP in migraine patients – a review of pros and cons. J Headache Pain 18:96

    Article  Google Scholar 

  2. Tiseo C, Ornello R, Pistoia F, Sacco S (2019) How to integrate monoclonal antibodies targeting the calcitonin gene-related peptide or its receptor in daily clinical practice. J Headache Pain 20(1):49

    Article  Google Scholar 

  3. Sacco S, Bendtsen L, Ashina M, Reuter U, Terwindt G, Mitsikostas DD et al (2019) European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention. J Headache Pain 20(1):6

    Article  Google Scholar 

  4. Haanes KA, Edvinsson L, Sams A (2020) Understanding side-effects of anti-CGRP and anti-CGRP receptor antibodies. J Headache Pain 21:26

    Article  Google Scholar 

  5. Joshi N, McAree M, Klimowich K, Cahill K, Janora D (2020) Oral candidiasis in a migraine patient taking erenumab and galcanezumab: a case report. SN Compr Clin Med 2:658–661

    Article  Google Scholar 

  6. Goadsby PJ, Reuter U, Hallström Y, Broessner G, Bonner JH, Zhang F, Sapra S, Picard H, Mikol DD, Lenz RA (2017) A controlled trial of erenumab for episodic migraine. N Engl J Med 377:2123–2132

    Article  CAS  Google Scholar 

  7. Dodick DW, Ashina M, Brandes JL, Kudrow D, Lanteri-Minet M, Osipova V, Palmer K, Picard H, Mikol DD, Lenz RA (2018) ARISE: a phase 3 randomized trial of erenumab for episodic migraine. Cephalalgia 38(6):1026–1037

    Article  Google Scholar 

  8. Tepper S, Ashina M, Reuter U, Brandes JL, Doležil D, Silberstein S, Winner P, Leonardi D, Mikol D, Lenz R (2017) Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol 16:425–434

    Article  CAS  Google Scholar 

  9. Sun H, Dodick DW, Silberstein S, Goadsby PJ, Reuter U, Ashina M, Saper J, Cady R, Chon Y, Dietrich J, Lenz R (2016) Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol 15:382–390

    Article  CAS  Google Scholar 

  10. Ornello R, Casalena A, Frattale I, Gabriele A, Affaitati G, Giamberardino MA, Assetta M, Maddestra M, Marzoli F, Viola S, Cerone D, Marini C, Pistoia F, Sacco S (2020) Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy. J Headache Pain 21:32

    Article  CAS  Google Scholar 

  11. Robbins L, Phenicie B (2018) Early data on the 1st migraine inhibiting CGRP. Available at http://www.practicalpainmanagement.com/issue/1808. Accessed Apr 2020

Download references

Acknowledgements

None.

Funding

None.

Author information

Authors and Affiliations

  1. Neuroscience Section, Department of Applied Clinical Sciences and Biotechnology, University of L’Aquila, 67100, L’Aquila, Italy

    Ilaria Frattale, Raffaele Ornello, Francesca Pistoia, Valeria Caponnetto, Enrico Colangeli & Simona Sacco

Authors
  1. Ilaria Frattale
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Raffaele Ornello
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francesca Pistoia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Valeria Caponnetto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Enrico Colangeli
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Simona Sacco
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study conception and design. Material preparation and data collection were performed by IF, RO, FP, VC, EC and SS. The first draft of the manuscript was written by IF and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Ilaria Frattale.

Ethics declarations

Conflict of interest

I Frattale has no conflict of interest to be disclosed; R Ornello has received sponsorship to attend meetings from Novartis and Teva; F Pistoia has no conflict of interest to be disclosed; E Colangeli has no conflict of interest to be disclosed; V Caponnetto has received a sponsorship (lecturer of advisory board) from Novartis; S Sacco had a financial relationship (lecturer or member of advisory board) with Abbott, Allergan, Novartis, Teva, and Eli Lilly, Medscape. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or conflict with the subject matter or materials discussed in this manuscript apart from those disclosed.

Statements on human and animal rights

All procedures followed were in accordance with the Declaration of Helsinki.

Informed consent

A written informed consent was obtained from the patient prior to the publication of this case.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Frattale, I., Ornello, R., Pistoia, F. et al. Paralytic ileus after planned abdominal surgery in a patient on treatment with erenumab. Intern Emerg Med 16, 227–228 (2021). https://doi.org/10.1007/s11739-020-02407-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-020-02407-y

Search

Navigation